MET vs PROF · P/E 13, $52.16B cap vs rev $10.7M
MetLife Inc (MET) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
MetLife Inc (MET) is a insurance - life company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
MET does not have a complete income-statement cache yet.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
MET currently screens at market cap $52.16B and trailing P/E 12.7. PROF currently screens at market cap $238.7M.
Not investment advice. Open the MET and PROF stock pages for the full models.
Not investment advice.